title: Testosterone content of developing eggs and sex reversal in the medaka (Oryzias latipes).
abstract: To understand the effect of testosterone on sex differentiation, the quantities of testosterone (T) and estradiol-17beta (E2) in developing eggs of medaka (Oryzias latipes) were measured by radioimmunoassay, and the influence on sex differentiation of treating embryos with exogenous androgens was also examined. Endogenous T of eggs dispersed into the environmental water at spawning, and precipitously declined to a minimum level during incubation for 2 days post-fertilization (dpf). It did not significantly increase during development. The E2 content of fertilized eggs increased when eggs were incubated in medium containing exogenous T at the concentrations of 100 and 500 ng/ml, but not in low concentrations of 10 ng/ml or less. The presence of 500 ng/ml 17alpha-methyltestosterone (MT) in the incubation medium also induced an increase in the E2 content of embryos. Exposure of embryos to exogenous 1 ng/ml T that corresponded with the level of T in eggs shortly after fertilization was enough to induce sex reversal of genotypic females to functional males. The co-existence of T and aromatase inhibitor in incubation medium inhibited not only the T-induced increase in the embryonic E2 content, but also the estrogenic effect of T in causing the paradoxical sex reversal from genotypic males to phenotypic females. However, treatment of embryos with the non-aromatizable androgen, 17alpha-methyldihydrotestosterone, induced no detectable increase in the E2 content of embryos, but still brought about sex reversal of genotypic males into females. This contradictory result suggests that the conversion of androgens to E2 may not always be the cause for induction of paradoxical sex reversal by T treatment. Consequently, these results on sex reversal induced by treatment of embryos with exogenous androgens suggest that endogenous T of developing medaka embryos may not act as the natural andro-inducer, and that genotypic sex can be modified by exogenous sex steroids at early developmental stages long before gonadal differentiation in the medaka.
authors.affiliation: Department of Biology, Aichi University of Education, Kariya 448-8542, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Iwamatsu
authors.forename: Hirokuni
authors.initials: H
authors.lastname: Kobayashi
authors.forename: Reiko
authors.initials: R
authors.lastname: Sagegami
authors.forename: Takuya
authors.initials: T
authors.lastname: Shuo
mesh_terms: D000818:Animals; D047072:Aromatase Inhibitors / Q000494:pharmacology; D013196:Dihydrotestosterone / Q000031:analogs & derivatives / Q000494:pharmacology; D004958:Estradiol / Q000032:analysis; D005260:Female; D005306:Fertilization; D008297:Male; D008777:Methyltestosterone / Q000494:pharmacology; D009990:Oryzias / Q000196:embryology*; D010063:Ovum / Q000737:chemistry* / Q000187:drug effects; D012733:Sex Differentiation / Q000187:drug effects / Q000502:physiology; D013739:Testosterone / Q000032:analysis* / Q000494:pharmacology
chemical_list: D047072:Aromatase Inhibitors; D013196:Dihydrotestosterone; D013739:Testosterone; D004958:Estradiol; C008376:mestanolone; D008777:Methyltestosterone